Clinical Trial

Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2025 (before its estimated August 8, 2026 completion). Its status may not reflect the trial's current state.
Summary
1. To evaluate the efficacy and safety of topical resveratrol 1 % gel in treatment of melasma. 2. To compare between the efficacy of topical resveratrol 1 %gel versrs chemical peeling with TCA 20% in melasma.
Trial Details
NCT Number NCT07060157
Lead Sponsor Assiut University
Conditions Melasma
Enrollment 41 participants
Start Date 2025-07-22
Primary Completion 2026-08-08 (estimated)
Study Completion 2027-06-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-11